206 related articles for article (PubMed ID: 31792580)
1. [Drug-induced interstitial lung disease (DILD) during treatment with ustekinumab].
Sorger C; Simon JC; Treudler R
Hautarzt; 2020 Apr; 71(4):309-312. PubMed ID: 31792580
[TBL] [Abstract][Full Text] [Related]
2. Interstitial pneumonia in two patients with psoriasis during ustekinumab treatment.
Kikuchi S; Umezawa Y; Hayashi M; Yanaba K; Fukuchi O; Ito T; Asahina A; Saeki H; Nakagawa H
J Dermatol; 2016 Jun; 43(6):712-3. PubMed ID: 26703791
[No Abstract] [Full Text] [Related]
3. [Ustekinumab-induced eosinophilic pneumonia during the course of ustekinumab therapy for plaque psoriasis].
Amy de la Bretèque M; Appere-De Vecchi C; Zeboulon C; Zaien I; Sigal ML; Mahé E
Ann Dermatol Venereol; 2015 Mar; 142(3):193-6. PubMed ID: 25624139
[TBL] [Abstract][Full Text] [Related]
4. A Case of Interstitial Lung Disease and Autoimmune Thyroiditis Associated with Ustekinumab.
Lee SG; An JH; Kim DH; Yoon MS; Lee HJ
Acta Derm Venereol; 2019 Mar; 99(3):331-332. PubMed ID: 30426134
[No Abstract] [Full Text] [Related]
5. Psoriasis vulgaris complicated by eosinophilic pneumonia during ustekinumab treatment.
Yashiro M; Maejima H; Taniguchi T; Katsuoka K; Kimura M; Wada M
Eur J Dermatol; 2013; 23(3):396-7. PubMed ID: 23728153
[No Abstract] [Full Text] [Related]
6. Psoriasis-associated interstitial pneumonia.
Hara H; Kuwano K; Kawamoto H; Nakagawa H
Eur J Dermatol; 2018 Jun; 28(3):395-396. PubMed ID: 29521628
[No Abstract] [Full Text] [Related]
7. Safety of ustekinumab for the treatment of psoriasis vulgaris with myotonic dystrophy.
Fujita Y; Shinkuma S; Nomura T; Shimizu H
Eur J Dermatol; 2016 Apr; 26(2):187-8. PubMed ID: 26643260
[No Abstract] [Full Text] [Related]
8. Respiratory failure due to infliximab induced interstitial lung disease.
Kakavas S; Balis E; Lazarou V; Kouvela M; Tatsis G
Heart Lung; 2013; 42(6):480-2. PubMed ID: 23969008
[TBL] [Abstract][Full Text] [Related]
9. Reversible Posterior Leukoencephalopathy Syndrome (RPLS) in a Psoriasis Patient Treated With Ustekinumab.
Dickson L; Menter A
J Drugs Dermatol; 2017 Feb; 16(2):177-179. PubMed ID: 28300862
[TBL] [Abstract][Full Text] [Related]
10. Risankizumab versus ustekinumab for moderate-to-severe plaque psoriasis.
Fioranelli M; Roccia MG; Lotti T
Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28508536
[No Abstract] [Full Text] [Related]
11. Ustekinumab for the treatment of psoriasis: an evidence update.
Yiu ZZ; Warren RB
Semin Cutan Med Surg; 2018 Sep; 37(3):143-147. PubMed ID: 30215630
[TBL] [Abstract][Full Text] [Related]
12. Safety of ustekinumab in severe psoriasis with chronic hepatitis B.
Raymundo AR; Facin AP; Silva de Castro CC; Faria AR
Indian J Dermatol Venereol Leprol; 2016; 82(3):326-8. PubMed ID: 27088944
[No Abstract] [Full Text] [Related]
13. Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.
Čarija A; Ivić I; Marasović-Krstulović D; Puizina-Ivić N
Rheumatology (Oxford); 2015 Nov; 54(11):2114-6. PubMed ID: 26242857
[No Abstract] [Full Text] [Related]
14. Sarcoid- like Phenomenon - ustekinumab induced granulomatous reaction mimicking diffuse metastatic disease: a case report and review of the literature.
Gad MM; Bazarbashi N; Kaur M; Gupta A
J Med Case Rep; 2019 Jul; 13(1):257. PubMed ID: 31358038
[TBL] [Abstract][Full Text] [Related]
15. Worsening of Psoriatic Arthritis After Ustekinumab Treatment.
Onsun N; Yalcin B; Sallahoglu K; Rezvani A
Am J Ther; 2018; 25(3):e381-e382. PubMed ID: 29189317
[No Abstract] [Full Text] [Related]
16. Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period.
Megna M; Napolitano M; Balato N; Monfrecola G; Villani A; Ayala F; Balato A
Clin Exp Dermatol; 2016 Jul; 41(5):564-6. PubMed ID: 27028505
[No Abstract] [Full Text] [Related]
17. Liver Injury in Psoriasis Patients Receiving Ustekinumab: A Retrospective Study of 44 Patients Treated in the Clinical Practice Setting.
Llamas-Velasco M; Concha-Garzón MJ; García-Diez A; Daudén E
Actas Dermosifiliogr; 2015; 106(6):470-6. PubMed ID: 25912374
[TBL] [Abstract][Full Text] [Related]
18. Intracranial hypertension syndrome in a patient with psoriasis receiving ustekinumab.
Reyes Bueno JA; Reyes Garrido V; León A; Bustamante R
Neurologia (Engl Ed); 2019 May; 34(4):281-282. PubMed ID: 28712842
[No Abstract] [Full Text] [Related]
19. An analysis of Drug Survival, Effectiveness, and Safety in Moderate to Severe Psoriasis Treated With Ustekinumab: An Observational Study of 69 Patients in Routine Clinical Practice.
Salgüero Fernández I; Gil MH; Sanz MS; Gullón GR
Actas Dermosifiliogr (Engl Ed); 2019 Apr; 110(3):244-246. PubMed ID: 29961546
[No Abstract] [Full Text] [Related]
20. Atopic dermatitis exacerbated with ustekinumab in a psoriatic patient with childhood history of atopy.
Lis-Święty A; Skrzypek-Salamon A; Arasiewicz H; Brzezińska-Wcisło L
Allergol Int; 2015 Oct; 64(4):382-3. PubMed ID: 26433537
[No Abstract] [Full Text] [Related]
[Next] [New Search]